The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Evolent Health Inc shares valued at $731,790 were sold by McCarthy Daniel Joseph on Aug 22 ’24. At $30.89 per share, McCarthy Daniel Joseph sold 23,693 shares. The insider’s holdings dropped to 198,809 shares worth approximately $2.53 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, McCarthy Daniel Joseph sold 10,469 shares, netting a total of over 339,008 in proceeds. Following the sale of shares at $32.38 each, the insider now holds 188,340 shares.
Before that, Weinberg Jonathan had sold 42,140 shares from its account. In a trade valued at $1,314,706, the General Counsel traded Evolent Health Inc shares for $31.20 each. Upon closing the transaction, the insider’s holdings decreased to 42,140 shares, worth approximately $2.13 million.
As published in a research note from Stephens on November 08, 2024, Evolent Health Inc [EVH] has been rated down from an Overweight to an Equal-weight and the price target has been revised to $16 from $38. Analysts at KeyBanc Capital Markets started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid October. As of August 09, 2024, Truist has increased its “Hold” rating to a “Buy” for EVH. Earlier on April 22, 2024, Citigroup initiated its rating. Their recommendation was “a Buy” for EVH stock.
Analyzing EVH Stock Performance
During the last five days, there has been a drop of approximately -48.53%. Over the course of the year, Evolent Health Inc shares have dropped approximately -61.40%. Shares of the company reached a 52-week high of $35.00 on 03/04/24 and a 52-week low of $12.37 on 11/13/24. A 50-day SMA is recorded $25.82, while a 200-day SMA reached $26.65. Nevertheless, trading volume fell to 4.74 million shares from 3.75 million shares the previous day.
Support And Resistance Levels for Evolent Health Inc (EVH)
According to the 24-hour chart, there is a support level at 11.90, which, if violated, would cause prices to drop to 11.06. In the upper region, resistance lies at 14.06. The next price resistance is at 15.38. RSI (Relative Strength Index) is 22.94 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -6.88, which suggests the price will decrease in the coming days. Percent R is at 97.04%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
